Oliguria: Difference between revisions
No edit summary |
|||
Line 19: | Line 19: | ||
{|style="width:82%; height:100px" border="1" | {|style="width:82%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Accelerated hypertension]], [[Acute systemic inflammation following acute myocardial infarction]], [[Aneurysmal rupture]], [[Aortic valve ring and critical aortic stenosis]], [[Atheroemboli]], [[Bleeding]], [[Bradyarrhythmias ]], [[Capillary leak]], [[Cardiogenic shock]], [[Cholesterol embolism]], [[Complete heart block]], [[Congenital heart disease]], [[Dilated cardiomyopathies]], [[Heart failure]], [[Heat stroke]], [[Hypovolemic shock]], [[Malignant hypertension]], [[myocardial depression ]], [[myocardial shock]], [[Myocardial stunning ]], [[pericardial tamponade, ]], [[Preclampsia]], [[Renal artery stenosis]], [[severe constrictive pericarditis ]], [[Superior mesenteric artery occlusion]], [[vasculitis ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Chemical/Poisoning''' | | '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Camphor]], [[Carbon-monoxide]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 31: | Line 31: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anaphylaxis and anaphylactoid reactions]], [[Erythroderma]], [[Sweating]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[ACE inhibitors]], [[Amatoxins]], [[Aminoglycosides]], [[Amphotericin B]], [[Analgesic nephropathy]], [[Anthracyclines]], [[Arsenic trioxide]], [[Bacitracin]], [[Bendamustine]], [[Bleomycin]], [[Capecitabine]], [[Capreomycin]], [[Carbon tetrachloride]], [[Carboplatin]], [[Carmustine]], [[Cidofovir]], [[Cisplatin]], [[Cyclophosphamide]], [[Cyclosporine]], [[Cytarabine]], [[Deferasirox]], [[Etoposide]], [[Exenatide]], [[Fluconazole]], [[Fludarabine and cladribine]], [[Gallium nitrate]], [[Gemcitabine]], [[Gyromitrin]], [[Hetastarch ]], [[Hydroxyurea]], [[Ifosfamide]], [[Intravenous immune globulin]], [[Irinotecan]], [[Lenalidomide]], [[Lomustine]], [[Malignant hyperpyrexia following anesthesia]], [[Mannitol]], [[Melphalan]], [[Methotrexate]], [[Micafungin]], [[Mithramycin]], [[Nitrosourea compounds]], [[NSAIDs ]], [[Orellanine]], [[Oxaliplatin]], [[Para-amino salicylic acid]], [[Pemetrexed]], [[Pentamidine]], [[Pentostatin]], [[Polymyxin B]], [[Rifampicin]], [[Sulphinpyrazone]], [[Sulphonamide crystalluria Cacluli]], [[Synthetic cannabinoids ]], [[Tacrolimus]], [[Taxanes]], [[Telavancin]], [[Temozolomide]], [[Tenofovir]], [[Topotecan]], [[Valacyclovir]], [[Vancomycin]], [[Vinca alkaloids]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 43: | Line 43: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Acute pancreatitis]], [[Addisonian crisis]], [[Diabetic nephropathy]], [[Hypercalciuria]], [[Hyperosmolar non-ketotic diabetic coma]], [[hypoaldosteronism]], [[Myxedema coma]], [[SIADH]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Burns]], [[Heat stroke]], [[Insect bites]], [[Snake bite (Viperidae)]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bowel strangulation]], [[Colorectal cancer]], [[Hemorrhagic pancreatitis]], [[Hepatic vein thrombosis]], [[Hepatorenal syndrome]], [[Intestinal obstruction, ]], [[Intususception of intestine]], [[Acute Pancreatitis]], [[Retroperitoneal fibrosis]], [[Third-space sequestration]], [[Upper or Lower gastrointestinal bleeding]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Prune belly syndrome]], [[Thrombotic thrombocytopenic purpura]], [[Transient renal dysfunction of the newborn]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Disseminated intravascular coagulation]], [[Expanding hematoma]], [[Mismatched blood transfusion]], [[Myoglobinuria]], [[Polycythemia]], [[Porphyria]], [[Renal artery thrombosis]], [[Renal vein thrombosis]], [[Thrombotic thrombocytopenic purpura]], [[transfusion reactions]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Diarrhea]], [[external drainage]], [[Malignant hyperpyrexia following anesthesia]], [[Mismatched blood transfusion]], [[Multiple organ dysfunction syndrome]], [[Radiotherapy]], [[sweating]], [[Systemic inflammatory response syndrome ]], [[Vomiting]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Diphtheria]], [[Dobrava-Belgrade Virus]], [[Endometriosis]], [[Endotoxic shock]], [[Enteritis]], [[Epidemic dropsy]], [[Hantavirus]], [[Human monocytotropic ehrlichiosis]], [[Lassa fever]], [[Leptospirosis]], [[Malignant malaria]], [[Mycobacterium tuberculosis]], [[Neisseria gonorrhoea]], [[Post-streptococcal glomerulonephritis]], [[Schistosoma haematobium]], [[septic shock ]], [[Systemic inflammatory response syndrome ]], [[Toxic shock syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Rhabdomyolysis]], [[Cervical spine injury]], [[Spinal cord compression]], [[Crush syndrome]], [[fractures]], [[Massive bleeding]], [[Multiple traumatic injuries]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cervical spine injury]], [[Eclampsia]], [[Intraventricular hemorrhage]], [[Myelomatosis]], [[Neurogenic bladder]], [[neurogenic shock after central nervous system or spinal cord injury]], [[Prolonged convulsions]], [[Spinal cord compression]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Adenine phosphoribosyltransferase deficiency]], [[Bulimia]], [[Cholesterol embolism]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Carcinoma of the uterine cervix]], [[Cervical cancer]], [[Endometriosis]], [[Hydrometrocolpos]], [[Hyperemesis gravidarum]], [[Ovarian hyperstimulation syndrome]], [[Perinatal asphyxia]], [[Postpartum bleeding]], [[Preclampsia]], [[Toxemia of pregnancy (type of Toxemia)]], [[Twin twin transfusion]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Benign Prostate hyperplasia]], [[Bladder cancer]], [[Leukaemia]], [[Pelvic tumor]], [[Prostate cancer]], [[Tumor lysis syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 95: | Line 95: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Crush syndrome]], [[Drug overdose]], [[heavy metal poisoning ]], [[Heme pigments ]], [[Myoglobinuria]], [[Porphyria]], [[Radiocontrast media ]], [[Rhabdomyolysis]], [[Tumor lysis syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bulimia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Alport syndrome]], [[Massive pulmonary embolism,]], [[Respiratory distress syndrome]], [[Respiratory losses ]], [[Severe pulmonary hypertension]], [[Tension pneumothorax]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Acute cortical necrosis]], [[Acute glomerulonephritis]], [[Acute interstitial nephritis]], [[Acute on chronic renal failure ]], [[Acute pyelonephritis]], [[Acute renal failure]], [[Acute tubular necrosis]], [[Addisonian crisis]], [[Alport syndrome]], [[Analgesic nephropathy]], [[Bilateral renal vein occlusion]], [[Burns]], [[Chronic renal failure]], [[End stage kidney disease]], [[Glomerulonephritis ]], [[Hepatic vein thrombosis]], [[Hepatorenal syndrome]], [[Hydronephrosis]], [[hypoaldosteronism]], [[Interstitial nephritis]], [[Intrinsic glomerular disease]], [[Nephritic syndrome]], [[Nephrocalcinosis ]], [[Nephrolithiasis]], [[Nephrotic syndrome]], [[Post-streptococcal glomerulonephritis]], [[Prerenal failure]], [[Renal insufficiency]], [[Renal papillary necrosis]], [[Renal vein thrombosis]], [[salt-wasting nephropathies ]], [[Sulphonamide crystalluria Cacluli]], [[Thrombotic thrombocytopenic purpura]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Anaphylaxis and anaphylactoid reactions]], [[Antiphospholipid Antibody Syndrome]], [[Disseminated intravascular coagulation]], [[Lichen sclerosus et atrophicus]], [[Mismatched blood transfusion]], [[Multiple organ dysfunction syndrome]], [[Systemic lupus erythematosis]], [[Systemic inflammatory response syndrome ]], [[transfusion reactions]], [[Transplant rejection]], [[vasculitis ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Sexual''' | | '''Sexual''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Benign Prostate hyperplasia]], [[Hydrometrocolpos]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Acute blood loss]], [[Cervical spine injury]], [[Crush syndrome]], [[fractures]], [[Massive bleeding]], [[Multiple traumatic injuries]], [[Neurogenic bladder]], [[Neurogenic shock after central nervous system or spinal cord injury]], [[Ruptured hematoma]], [[Shock]], [[Upper or Lower gastrointestinal bleeding]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Benign Prostate hyperplasia]], [[Bladder cancer]], [[Bladder outlet obstruction]], [[Hydronephrosis]], [[Kidney stone]], [[Nephrotic syndrome]], [[Obstruction of the urinary tract]], [[Pelvic tumor]], [[Prostate cancer]], [[Schistosoma haematobium]], [[Sulphonamide crystalluria Cacluli]], [[Ureterocele]], [[Urethral catheterization]], [[Urethral stricture]], [[Urethral trauma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Puerperal shock]], [[Radiotherapy]], [[Surgery complication]] | ||
|- | |- | ||
|} | |} |
Revision as of 18:37, 10 July 2013
WikiDoc Resources for Oliguria |
Articles |
---|
Most recent articles on Oliguria |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Oliguria at Clinical Trials.gov Clinical Trials on Oliguria at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Oliguria
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Oliguria Risk calculators and risk factors for Oliguria
|
Healthcare Provider Resources |
Causes & Risk Factors for Oliguria |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
For patient information page click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Decreased urine output; reduced urine output
Overview
Oliguria and anuria are the decreased or absent production of urine, respectively.
Oliguria is defined as a urine output that is less than 1 mL/kg/h in infants, less than 0.5 mL/kg/h in children, and less than 400 mL/day (equals 17mL/hour) in adults.[1]
Causes
Common Causes
- List the most common causes here.
Causes by Organ System
Causes in Alphabetical Order
|
|
|
The mechanisms causing oliguria can be divided into several categories:
Prerenal
In response to hypoperfusion of the kidney (e.g. as a result of dehydration by poor oral intake, diarrhea, massive bleeding or sepsis)
Renal
Due to kidney damage (severe hypoperfusion, rhabdomyolysis, medication)
Postrenal
As a consequence of obstruction of the urine flow (e.g. enlarged prostate, tumor compression urinary outflow, expanding hematoma or fluid collection)
The decreased production of urine may be a sign of dehydration, renal failure or urinary obstruction/urinary retention.
Postoperative Oliguria
Patients usually have a decrease in urine output after a major operation that may be a normal physiological response to:
- Fluid/blood loss – decreased glomerular filtration rate secondary to hypovolemia and/or hypotension
- Response of adrenal cortex to stress -increase in aldosterone (Na and water retention) and antidiuretic hormone (ADH) release
Oliguria in Infants
Oliguria, when defined as less than 1 mL/kg/h, in infants is not considered to be a reliable sign of renal failure.[2]==Risk Factors== Patients having any of the conditions mentioned in the causes are at risk of oliguria.
Natural History, Complications and Prognosis
Although a significant decrease in urine output may indicate a serious, even life-threatening condition, adequate urine output can be restored with prompt medical treatment.
Diagnosis
History and Symptoms
History of
- Time pattern
- When did this begin?
- Did it occur suddenly?
- Has it rapidly become worse?
- Quality
- How much does the patient drink each day?
- Does drinking more increase the daily urine output?
- How much urine does the patient produce each day?
- What color is the urine?
- Aggravating factors
- Other
- What medications does the patient take?
- Does the patient have any allergies?
- Does the patient have access to adequate fluids?
- Medical history
Laboratory Findings
- Blood studies to monitor electrolytes and kidney function.
- Urine tests, including tests for infection.
Treatment
Medical Therapy
It mainly depends on the cause:
Home Care
The patient should follow prescribed fluid regimens and measure urine output as directed.
Primary Prevention
Prevention depends on the underlying cause.
References
- ↑ Klahr S, Miller S (1998). "Acute oliguria". N Engl J Med. 338 (10): 671–5. PMID 9486997. Free Full Text.
- ↑ Arant B (1987). "Postnatal development of renal function during the first year of life". Pediatr Nephrol. 1 (3): 308–13. PMID 3153294.